Vitamin A
Vitamin A
Uses
Other Proposed Uses
- Acne
- Aging Skin
- Crohn's Disease
- Diabetes
- Eczema
- HIV Support
- Menorrhagia (Heavy Menstruation)
- Psoriasis
- Retinitis Pigmentosa
- Rosacea
- Seborrhea
Requirements/Sources
-
Infants
- 0-6 months: 400 mcg RAE or 1,330 IU
- 7-12 months: 500 mcg RAE or 1,665 IU
-
Children
- 1-3 years: 300 mcg RAE or 1,000 IU
- 4-8 years: 400 mcg RAE or 1,330 IU
-
Males
- 9-13 years: 600 mcg RAE or 2,000 IU
- 14 years and older: 900 mcg RAE or 3,000 IU
-
Females
- 9-13 years: 600 mcg RAE or 2,000 IU
- 14 years and older: 700 mcg RAE or 2,330 IU
-
Pregnant Women
- 18 years or younger: 750 mcg RAE or 2,500 IUs
- 19 years and older: 770 mcg RAE or 2,560 IU
-
Nursing Women
- 18 years or younger: 1,200 mcg RAE or 4,000 IUs
- 19 years and older: 1,300 mcg RAE or 4,300 IU
Therapeutic Dosages
Therapeutic Uses
What Is the Scientific Evidence for Vitamin A?
Diabetes
Menorrhagia (Heavy Menstruation)
HIV Support
Crohn's Disease
Lower Respiratory Tract Infections
Safety Issues
-
Infants
- 0-12 months: 600 mcg RAE or 2,000 IU
-
Children
- 1-3 years: 600 mcg RAE or 2,000 IU
- 4-8 years: 900 mcg RAE or 3,000 IU
-
Males and Females
- 9-13 years: 1,700 mcg RAE or 5,660 IUs
- 14-18 years: 2,800 mcg RAE or 9,320 IUs
- 19 years and older: 3,000 mcg RAE or 10,000 IU
-
Pregnant Women
- 18 years old or younger: 2,800 mcg RAE or 9,320 IU
- 19 years and older: 3,000 mcg RAE or 10,000 IU
-
Nursing Women
- 18 years old or younger: 2,800 mcg RAE or 9,320 IU
- 19 years and older: 3,000 mcg RAE or 10,000 IU
Interactions You Should Know About
- Isotretinoin (Accutane) : Don't take vitamin A, as the two might enhance each other's toxicity.
- Valproic acid (Depakote, Depacon, or Depakene) and you are pregnant : Do not take vitamin A supplements unless advised to do so by a physician.
- Warfarin (Coumadin): Do not take vitamin A supplements unless advised to do so by a physician.
References
1 Combs G. The Vitamins. 2nd ed. New York, NY: Academic Press; 1998:5-6.
2 West RJ, Lloyd JK. The effect of cholestyramine on intestinal absorption. Gut. 1975;16:93-98.
3 Glasziou PP, Mackerras DE. Vitamin A supplementation in infectious diseases: a meta-analysis. BMJ. 1993;306:366-370.
4 Lithgow DM, Politzer WM. Vitamin A in the treatment of menorrhagia. S Afr Med J. 1977;51:191-193.
5 Semba RD, Graham NM, Caiaffa WT, et al. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch Intern Med. 1993;153:2149-2154.
6 Bianchi-Santamaria A, Fedeli S, Santamaria L. Short communication: possible activity of beta-carotene in patients with the AIDS related complex. A pilot study. Med Oncol Tumor Pharmacother. 1992;9:151-153.
7 Alexander M, Newmark H, Miller RG. Oral beta-carotene can increase the number of OKT4+ cells in human blood. Immunol Lett. 1985;9:221-224.
8 Fryburg DA, Mark RJ, Griffith BP, et al. The effect of supplemental beta-carotene in immunologic indices in patients with AIDS: a pilot study. Yale J Biol Med. 1995;68:19-23.
9 Coodley GO, Nelson HD, Loveless MO, et al. Beta-carotene in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1993;6:272-276.
10 Coodley GO, Coodley MK, Lusk R, et al. Beta-carotene in HIV infection: an extended evaluation. AIDS. 1996;10:967-973.
11 Constans J, Delmas-Beauvieux MC, Sergeant C, et al. One-year antioxidant supplementation with beta-carotene or selenium for patients infected with human immunodeficiency virus: a pilot study. Clin Infect Dis. 1996;23:654-656.
12 Wright JP, Mee AS, Parfitt A, et al. Vitamin A therapy in patient's with Crohn's disease. Gastroenterology. 1985;88:512-514.
13 Glasziou PP, Mackerras DE. Vitamin A supplementation in infectious diseases: a meta-analysis. BMJ. 1993;306:366-370.
14 Bresee JS, Fischer M, Dowell SF, et al. Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States. Pediatr Infect Dis J. 1996;15:777-782.
15 Neuzil KM, Gruber WC, Chytil F, et al. Safety and pharmacokinetics of vitamin A therapy for infants with respiratory syncytial virus infections. Antimicrob Agents Chemother. 1995;39:1191-1193.
16 Martinoli L, Di Felice M, Seghieri G, et al. Plasma retinol and alpha-tocopherol concentrations in insulin-dependent diabetes mellitus: their relationship to microvascular complications. Int J Vitam Nutr Res. 1993;63:87-92.
17 Singh RB, Niaz MA, Ghosh S, et al. Dietary intake and plasma levels of antioxidant vitamins in health and disease: a hospital-based case-control study. J Nutr Environ Med. 1995;5:235-242.
18 Basualdo CG, Wein EE, Basu TK. Vitamin A (retinol) status of first nation adults with non-insulin-dependent diabetes mellitus. J Am Coll Nutr. 1997;16:39-45.
19 Straub RH, Rokitzki L, Schumacher T, et al. No evidence of deficiency of vitamins A, E, beta-carotene, B1, B2, B6, B12 and folate in neuropathic type II diabetic women. Int J Vitam Nutr Res. 1993;63:239-240.
20 Facchini F, Coulston AM, Reaven GM. Relation between dietary vitamin intake and resistance to insulin-mediated glucose disposal in healthy volunteers. Am J Clin Nutr. 1996;63:946-949.
21 Stoesser AV, Nelson LS. Synthetic vitamin A in the treatment of eczema in children. Ann Allergy. 1952;10:703-704.
22 Kligman AM, Mills OH Jr, Leyden JJ, et al. Oral vitamin A in acne vulgaris. Preliminary report. Int J Dermatol. 1981;20:278-285.
23 Marrakchi S, Kim I, Delaporte E, et al. Vitamin A and E blood levels in erythrodermic and pustular psoriasis associated with chronic alcoholism. Acta Derm Venereol. 1994;74:298-301.
24 Brenner S, Horwitz C. Possible nutrient mediators in psoriasis and seborrheic dermatitis. II. Nutrient mediators: essential fatty acids; vitamins A, E and D; vitamins B1, B2, B6, niacin and biotin; vitamin C; selenium; zinc; iron. World Rev Nutr Diet. 1988;55:165-182.
25 Lithgow DM, Politzer WM. Vitamin A in the treatment of menorrhagia. S Afr Med J. 1977;51:191-193.
26 Coodley GO, Nelson HD, Loveless MO, et al. Beta-carotene in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1993;6:272-276.
27 Coodley GO, Coodley MK, Lusk R, et al. Beta-carotene in HIV infection: an extended evaluation. AIDS. 1996;10:967-973.
28 Constans J, Delmas-Beauvieux MC, Sergeant C, et al. One-year antioxidant supplementation with beta-carotene or selenium for patients infected with human immunodeficiency virus: a pilot study [letters]. Clin Infect Dis. 1996;23:654-656.
29 Tang AM, Graham NHM, Kirby AJ, et al. Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men. Am J Epidemiol. 1993;138:937-951.
30 Tang AM, Graham NM, Saah AJ. Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection. Am J Epidemiol. 1996;143:1244-1256.
31 Fawzi WW, Msamanga G, Hunter D, et al. Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania. J Acquir Immune Defic Syndr Hum Retrovirol. 2000;23:246-254.
32 Coutsoudis A, Pillay K, Spooner E, et al. Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. South African Vitamin A Study Group. AIDS. 1999;13:1517-1524.
33 Wright JP, Mee AS, Parfitt A, et al. Vitamin A therapy in patient's with Crohn's disease. Gastroenterology. 1985;88:512-514.
34 Leo MA, Lieber CS. Alcohol, vitamin A, and beta-carotene: adverse interactions, including hepatotoxicity and carcinogenicity. Am J Clin Nutr. 1999;69:1071-1085.
35 Melhus H, Michaelsson K, Kindmark A, et al. Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med. 1998;129:770-778.
36 Nau H, Tzimas G, Mondry M, et al. Antiepileptic drugs alter endogenous retinoid concentrations: a possible mechanism of teratogenesis of anticonvulsant therapy. Life Sci. 1995;57:53-60.
37 Harris JE. Interaction of dietary factors with oral anticoagulants: review and applications. J Am Diet Assoc. 1995;95:580-584.
38 Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press; 2001.
39 D'Souza RM, D'Souza R. Vitamin A for the treatment of children with measles—a systematic review. J Trop Pediatr. 2002;48:323-327.
40 Michaelsson K, Lithell H, Vessby B, et al. Serum retinol levels and the risk of fracture. N Engl J Med. 2003;348:287-294.
41 Moon TE, Levine N, Cartmel B, et al. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol Biomarkers Prev. 1997;6:949-956.
42 Alberts D, Ranger-Moore J, Einspahr J, et al. Safety and efficacy of dose-intensive oral vitamin A in subjects with sun-damaged skin. Clin Cancer Res. 2004;10:1875-1880.
43 Berson EL, Rosner B, Sandberg MA, et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol. 1993;111:761-72
44 Berson EL, Rosner B, Sandberg MA, et al. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. Arch Ophthalmol. 2004;122:1297-1305
45 Mehta S, Fawzi W. Effects of Vitamins, Including Vitamin A, on HIV/AIDS Patients. Vitam Horm. 2007;75:355-383.
46 Kafi R, Kwak HS, Schumacher WE, et al. Improvement of naturally aged skin with vitamin a (retinol). Arch Dermatol. 2007;143:606-612.
47 Chen H, Zhuo Q, Wang J, Wu T. Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age. Cochrane Database Syst Rev. 2011;(1):CD006090.
Revision Information
- Reviewer: EBSCO CAM Review Board
- Review Date: 07/2012 -
- Update Date: 07/25/2012 -



